Publikationen von Dummer, R.

Brüggemann, C., Kirchberger, M. C., Goldinger, S. M., Weide, B., Konrad, A., Erdmann, M., Schadendorf, D., Croner, R. S., Krähenbühl, L., Kähler, K. C., Hafner, C., Leisgang, W., Kiesewetter, F., Dummer, R., Schuler, G., Stürzl, M. und Heinzerling, L. (2017) Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab. Journal of Cancer Research and Clinical Oncology 143 (10), S. 1977-1984. Volltext nicht vorhanden.

Dummer, R., Becker, J. C., Eilles, Christoph, Schäfer, E., Börner, W. und Burg, G. (1993) T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma. The British journal of dermatology 128 (4), S. 399-403.

Schäfer, E., Dummer, R., Eilles, Christoph, Börner, W., Martin, R., Rendl, J. und Burg, G. (1991) Imaging pattern of radiolabelled lymphokine-activated killer cells in patients with metastatic malignant melanoma. European journal of nuclear medicine 18 (2), S. 106-110.

Dummer, R., Schäfer, E., Eilles, Christoph, Börner, W. und Burg, G. (1991) Lymphokine-activated killer-cell traffic in metastatic melanoma. Lancet 338 (8764), S. 456-457.

Dummer, R., Miller, K., Eilles, Christoph und Burg, G. (1991) The Skin: An Immunoreactive Target Organ during Interleukin-2 Administration. Dermatologica 183 (2), S. 95-99. Volltext nicht vorhanden.